Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

528 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both.
Yan RT, White M, Yan AT, Yusuf S, Rouleau JL, Maggioni AP, Hall C, Latini R, Afzal R, Floras J, Masson S, McKelvie RS; Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Investigators. Yan RT, et al. Among authors: latini r. Am J Cardiol. 2005 Sep 1;96(5):698-704. doi: 10.1016/j.amjcard.2005.04.048. Am J Cardiol. 2005. PMID: 16125499 Clinical Trial.
A systematic review: effect of angiotensin converting enzyme inhibition on left ventricular volumes and ejection fraction in patients with a myocardial infarction and in patients with left ventricular dysfunction.
Abdulla J, Barlera S, Latini R, Kjoller-Hansen L, Sogaard P, Christensen E, Kober L, Torp-Pedersen C. Abdulla J, et al. Among authors: latini r. Eur J Heart Fail. 2007 Feb;9(2):129-35. doi: 10.1016/j.ejheart.2006.05.002. Epub 2006 Jul 7. Eur J Heart Fail. 2007. PMID: 16829187 Free article. Review.
Causes of death in patients with acute myocardial infarction treated with angiotensin-converting enzyme inhibitors: findings from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-3 trial.
Pedrazzini G, Santoro E, Latini R, Fromm L, Franzosi MG, Mocetti T, Staszewsky L, Barlera S, Tognoni G, Maggioni AP; GISSI-3 Investigators. Pedrazzini G, et al. Among authors: latini r. Am Heart J. 2008 Feb;155(2):388-94. doi: 10.1016/j.ahj.2007.10.015. Epub 2007 Dec 19. Am Heart J. 2008. PMID: 18215613 Clinical Trial.
Declining Risk of Sudden Death in Heart Failure.
Shen L, Jhund PS, Petrie MC, Claggett BL, Barlera S, Cleland JGF, Dargie HJ, Granger CB, Kjekshus J, Køber L, Latini R, Maggioni AP, Packer M, Pitt B, Solomon SD, Swedberg K, Tavazzi L, Wikstrand J, Zannad F, Zile MR, McMurray JJV. Shen L, et al. Among authors: latini r. N Engl J Med. 2017 Jul 6;377(1):41-51. doi: 10.1056/NEJMoa1609758. N Engl J Med. 2017. PMID: 28679089 Free article.
Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction.
Shen L, Rørth R, Cosmi D, Kristensen SL, Petrie MC, Cosmi F, Latini R, Køber L, Anand IS, Carson PE, Granger CB, Komajda M, McKelvie RS, Solomon SD, Staszewsky L, Swedberg K, Huynh T, Zile MR, Jhund PS, McMurray JJV. Shen L, et al. Among authors: latini r. Eur J Heart Fail. 2019 Aug;21(8):974-984. doi: 10.1002/ejhf.1535. Epub 2019 Jul 4. Eur J Heart Fail. 2019. PMID: 31271255 Free PMC article.
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.
Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D, Nicolosi GL, Porcu M, Tognoni G; Gissi-HF Investigators. Tavazzi L, et al. Among authors: latini r. Lancet. 2008 Oct 4;372(9645):1223-30. doi: 10.1016/S0140-6736(08)61239-8. Epub 2008 Aug 29. Lancet. 2008. PMID: 18757090 Clinical Trial.
528 results